|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print September 5, 2001
Am J Physiol Cell Physiol, 10.1152/ajpcell.00256.2001
Submitted on June 8, 2001
Accepted on August 24, 2001
1 Pharmacology, Rush Presbyterian St. Luke's Medical Center, Chicago, IL, USA
2 Biological Chemistry, University of California, Davis, CA, USA
3 Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
4 Biological Chemistry, University of Michigan, Ann Arbor, MI, USA
* To whom correspondence should be addressed. E-mail: hlum{at}rush.edu.
The expression and function of PKI (endogenous inhibitor of cAMP-dependent protein kinase) in endothelial cells are unknown. In this study, overexpression of rabbit muscle PKI gene into endothelial cells inhibited the cAMP-mediated increase and exacerbated thrombin-induced decrease in endothelial barrier function. We investigated PKI expression in human pulmonary artery (HPAEC), foreskin microvessel (HMEC), and brain microvessel endothelial cells (HBMEC). RT-PCR using specific primers for human PKI
, human PKI
, and mouse PKIß sequences detected PKI
and PKI
mRNA in all three cell types. Sequencing and BLAST analysis indicated that forward and reverse DNA strands for PKI
and PKI
were of >96% identity with database sequences. RNase protection assays showed protection of the 542 nucleotides in HBMEC and HPAEC PKI
mRNA and 240 nucleotides in HBMEC, HPAEC, and HMEC PKI
mRNA. Western blot analysis indicated that PKI
protein was detected in all three cell types; whereas PKI
was found in HBMEC. In summary, endothelial cells from three different vascular beds express PKI
and PKI
, which may be physiologically important in endothelial barrier function.
This article has been cited by other articles:
![]() |
J. Qiao, O. Holian, B.-S. Lee, F. Huang, J. Zhang, and H. Lum Phosphorylation of GTP dissociation inhibitor by PKA negatively regulates RhoA Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1161 - C1168. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Huang, P. V. Subbaiah, O. Holian, J. Zhang, A. Johnson, N. Gertzberg, and H. Lum Lysophosphatidylcholine increases endothelial permeability: role of PKC{alpha} and RhoA cross talk Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L176 - L185. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, J.-C. Dai, S. A. Orellana, and E. M. Greenfield Endogenous Protein Kinase Inhibitor {gamma} Terminates Immediate-early Gene Expression Induced by cAMP-dependent Protein Kinase (PKA) Signaling: TERMINATION DEPENDS ON PKA INACTIVATION RATHER THAN PKA EXPORT FROM THE NUCLEUS J. Biol. Chem., January 28, 2005; 280(4): 2700 - 2707. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lum, J. Qiao, R. J. Walter, F. Huang, P. V. Subbaiah, K. S. Kim, and O. Holian Inflammatory stress increases receptor for lysophosphatidylcholine in human microvascular endothelial cells Am J Physiol Heart Circ Physiol, October 1, 2003; 285(4): H1786 - H1789. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Qiao, F. Huang, and H. Lum PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction Am J Physiol Lung Cell Mol Physiol, June 1, 2003; 284(6): L972 - L980. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |